Akiko Mii
Overview
Explore the profile of Akiko Mii including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
64
Citations
471
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Ishida M, Yamamoto S, Iwashige Y, Miyazawa S, Nakata H, Koichi S, et al.
Nephron
. 2025 Feb;
:1-17.
PMID: 39947166
Glomerular diseases with organized deposits can be classified into various etiologies. A diagnostic algorithm based on clinical and pathological findings has been proposed. However, some cases cannot be diagnosed using...
2.
Nakazato R, Mii A, Kamijo N, Tani T, Arakawa Y, Otsuka T, et al.
Health Sci Rep
. 2024 Dec;
7(12):e70260.
PMID: 39691562
Background And Aims: Hypertensive emergencies, characterized by elevated blood pressure (BP) and multiple organ damage, have poor prognosis. Patients occasionally show gradual improvement in renal function with appropriate antihypertensive treatment...
3.
Kosaka T, Takaori K, Izumiya A, Hirai D, Koizumi M, Yamamoto S, et al.
Intern Med
. 2024 Nov;
PMID: 39496448
A 64-year-old Japanese woman presented with gross hematuria and was diagnosed with stage IVB cervical cancer. Renal dysfunction was observed following chemoradiation therapy, and a renal biopsy revealed renal thrombotic...
4.
Yamamoto S, Yamamoto S, Takahashi M, Mii A, Okubo A, Toriu N, et al.
Kidney Int
. 2024 Jul;
106(3):470-481.
PMID: 38996810
ATP depletion plays a central role in the pathogenesis of kidney diseases. Recently, we reported spatiotemporal intracellular ATP dynamics during ischemia reperfusion (IR) using GO-ATeam2 mice systemically expressing an ATP...
5.
Tominaga K, Toda E, Takeuchi K, Takakuma S, Sakamoto E, Kuno H, et al.
Pathol Int
. 2024 Apr;
74(6):317-326.
PMID: 38634742
Immune checkpoint inhibitors (ICIs) can provide survival benefits to cancer patients; however, they sometimes result in the development of renal immune-related adverse events (irAEs). Tubulointerstitial nephritis (TIN) is the most...
6.
Kamano C, Mii A, Osono E, Kunugi S, Igarashi T, Yanagihara T, et al.
Histopathology
. 2023 Jun;
83(4):617-630.
PMID: 37340663
Aim: To clarify the clinicopathological characteristics and role of periglomerular angiogenesis in IgA nephropathy. Methods And Results: The renal biopsy specimens of 114 patients with IgA nephropathy were examined. Among...
7.
Arai H, Yamamoto S, Matsubara T, Miyake T, Tochio A, Mii A, et al.
Intern Med
. 2023 Jan;
62(18):2693-2698.
PMID: 36642524
Ponatinib is a novel multi-tyrosine kinase inhibitor (TKI) with potent inhibitory activity against refractory chronic myeloid leukemia (CML). Despite its high clinical efficacy, ponatinib induces various adverse events due to...
8.
Tagawa M, Terasaki M, Mii A, Toda E, Kajimoto Y, Kunugi S, et al.
Pediatr Res
. 2022 Oct;
93(7):1873-1882.
PMID: 36302857
Background: The intrauterine adverse environment during nephrogenesis reduces the nephron number, probably associates with impaired ureteric bud (UB) branching. Methods: The kidneys in C57/BL6 mice were irradiated with a single...
9.
Tani T, Sugino K, Hashimoto K, Mii A, Kashiwagi T, Shimizu A, et al.
Kidney Int Rep
. 2022 Oct;
7(10):2317-2318.
PMID: 36217512
No abstract available.
10.
Arai M, Mii A, Hirama A, Kaneko T, Kashiwagi T, Shimizu A, et al.
CEN Case Rep
. 2022 Jun;
12(1):14-22.
PMID: 35711019
Immunoglobulin G (IgG) nephropathy refers to a rare group of diseases characterized by deposits of IgG in the mesangial region. However, IgG nephropathy is controversial as a single disease entity,...